Trial intelligence / Profile preview

Quality of Recovery After TAVR With Different Sedation Regimens

NCT07556523Phase 4Recruiting

Start
Mar 2026
Primary completion
Apr 2028
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 4, randomised trial of propofol injection (veterinary), dexmedetomidine, midazolam and fentanyl in aortic valve stenosis (3 arms). Primary endpoint: Quality of Recovery on Postoperative Day 1. Started Mar 2026; status: recruiting.

02

Drugs

propofol injection (veterinary)dexmedetomidinemidazolamfentanyl
03

Conditions

aortic valve stenosis

Beyond the preview

Go deeper on NCT07556523.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07556523.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call